Celldex Therapeutics Presents Positive Preclinical Data from Inflammatory Bispecific Antibody Program CDX-622 at AAAAI 2025
- CDX-622 inhibits SCF and TSLP-dependent inflammatory signatures in human skin -- Phase 1 study in healthy volunteers ongoing ...
Nasdaq Stockholm approved the delisting of Millicom ( Tigo ) SDRs and set the last day of trading on March 17, 2025
Nasdaq Stockholm approved the delisting of Millicom ( Tigo ) SDRs and set the last day of trading on March ...
Ascot Announces Amendment of Previously Announced Equity Financing
Not for distribution to U.S. news wire services or dissemination in the United States.
Binance to Delist Tether and Other Stablecoins for EEA Users, Due to MiCA Regulations
The news of Tether's delisting comes as the firm appoints a new CFO in a "historic step" towards a full financial audit.
Odysight.ai to Participate at the 37th Annual ROTH Conference on March 17-18, 2025
Omer, Israel, March 03, 2025 ( GLOBE NEWSWIRE ) -- Odysight.ai Inc. ( Nasdaq: ODYS ) , a pioneering developer of AI systems for Predictive Maintenance ( PdM ) and Condition-Based Monitoring ( CBM ) , today announced its participation at the 37th Annual ROTH Conference on March 17-18, 2025, in ...
Synchronoss Unveils Capsyl Cloud at MWC Barcelona - A Turn-Key Personal Cloud Solution for Global Operators
Empowering Mobile Operators and Service Providers to Rapidly Launch and Monetize Consumer Cloud Services ...
Nexalin Technology Receives Notice of Allowance from the USPTO for Patent Covering Deep Intracranial Frequency Stimulation ( DIFS™ ) Technology for Opioid and Other Substance Use Disorders
Patent Strengthens Nexalin's Intellectual Property Portfolio and Highlights the Potential of DIFS™ Technology in Addressing Substance Use Disorders, Including Opioids, Alcohol, Cocaine and Methamphetamine Patent Strengthens Nexalin's Intellectual Property Portfolio and Highlights the Potential ...
Coherus to Report Fourth Quarter and Full Year 2024 Financial Results on March 10, 2025
REDWOOD CITY, Calif., March 03, 2025 ( GLOBE NEWSWIRE ) -- Coherus BioSciences, Inc. ( "Coherus," NASDAQ: CHRS ) today announced that its fourth quarter and full year 2024 financial results will be released after market close on Monday, March 10, 2025. Starting at 5:00 p.m.
Allogene Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update
SOUTH SAN FRANCISCO, Calif., March 03, 2025 ( GLOBE NEWSWIRE ) -- Allogene Therapeutics, Inc. ( Nasdaq: ALLO ) , a clinical-stage biotechnology company pioneering the development of allogeneic CAR T ( AlloCAR T™ ) products for cancer and autoimmune disease, today announced that it will report ...
uCloudlink Unveils Groundbreaking Innovations at MWC 2025: Redefining Connectivity for IoT, People, and Pets - Ucloudlink Group ( NASDAQ:UCL )
BARCELONA, Spain, March 3, 2025 /PRNewswire/ -- uCloudlink UCL, the world's first and leading mobile data traffic-sharing marketplace, is thrilled to announce its participation in MWC 2025, where it will showcase its latest innovations in connectivity.




